Report for Mu R

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects - Luo_2024_Pharmaceutics_16_
Author(s) : Luo X , Zhang Z , Mu R , Hu G , Liu L , Liu X
Ref : Pharmaceutics , 16 : , 2024
Abstract : Luo_2024_Pharmaceutics_16_
ESTHER : Luo_2024_Pharmaceutics_16_
PubMedSearch : Luo_2024_Pharmaceutics_16_
PubMedID: 38399287

Title : Effect of lentivirus-mediated peroxiredoxins 6 gene silencing on the phenotype of human gastric cancer BGC-823 cells - Mu_2022_J.Cancer.Res.Ther_18_411
Author(s) : Mu R , Li Y , Xing J , Lin R , Ye S , Zhang Y , Mu H , Guo X , An L
Ref : J Cancer Research Ther , 18 :411 , 2022
Abstract : Mu_2022_J.Cancer.Res.Ther_18_411
ESTHER : Mu_2022_J.Cancer.Res.Ther_18_411
PubMedSearch : Mu_2022_J.Cancer.Res.Ther_18_411
PubMedID: 35645108

Title : Effects of Peroxiredoxin 6 and Its Mutants on the Isoproterenol Induced Myocardial Injury in H9C2 Cells and Rats - Mu_2022_Oxid.Med.Cell.Longev_2022_2576310
Author(s) : Mu R , Ye S , Lin R , Li Y , Guo X , An L
Ref : Oxid Med Cell Longev , 2022 :2576310 , 2022
Abstract : Mu_2022_Oxid.Med.Cell.Longev_2022_2576310
ESTHER : Mu_2022_Oxid.Med.Cell.Longev_2022_2576310
PubMedSearch : Mu_2022_Oxid.Med.Cell.Longev_2022_2576310
PubMedID: 35378825